1. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes;Holzmann;Int. J. Cancer,1987
2. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage;Holzmann;Differential expression of two surface molecules, gp75 and p89. J. Exp. Med,1985
3. .P. Johnson, B.G. Stade, B. Holzmann, W. Schwäble, G. Riethmüller. De novo expression of cell adhesion molecule ICAM-1 in melanoma and increased risk of metastasis. Proc. Natl. Acad. Sci. U.S.A., in press.
4. Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen;Holzmann;Int. J. Cancer,1988
5. Subclass analysis and purification of monoclonal antibodies;Wood,1984